Kenai facility will boost Parkinson’s neuron replacement research
Kenai Therapeutics is setting up research and laboratory facilities at Lilly Gateway Labs in San Diego, to help…
Articles by Andrea Lobo
Strength training app aimed at people with Parkinson’s, MS
A research initiative aims to create a mobile app using artificial intelligence (AI) to make strength training at home more…
Plant compound eases motor, cognitive symptoms in mice
Gardenin A, a compound found in a common South Asian shrub, lessened both cognitive and motor symptoms of Parkinson’s…
Direct nose-to-brain delivery of dopamine is company’s goal
An Australian company announced that it is working on a direct, nose-to-brain way of delivering dopamine that might more effectively…
Aiming to empower Black, African American Parkinson’s patients
The Parkinson’s Foundation hosted a series of events last year that aimed to recognize the unique needs and experiences…
Could immune system ‘exhaustion’ contribute to Parkinson’s?
As people age, the immune system ages with them, becoming more sluggish and ineffective — a change that could contribute…
New microglia cell model aims to help advance Parkinson’s research
Ncardia has launched a human-derived microglia cell model, called Ncyte Microglia, that the company says may help advance research…
EU agency say no trials of mesdopetam in children are needed
The European Medicines Agency (EMA), which evaluates the safety and efficacy of new drugs in the European Union, has waived…
Sex or gender disparities clear in Parkinson’s, need attention: Report
Parkinson’s disease research and care should address disparities by sex and gender in patients’ symptoms, treatment responses, and disease…
Wireless DBS rallies neuron activity, motor function in Parkinson’s mice
A nanoparticle-based wireless deep brain stimulation (DBS) system restored the activity of degenerating neurons and increased dopamine release in…